Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-18
1987-10-06
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530317, 530322, A61K 3566, A61K 3702, C07K 750, C07K 900
Patent
active
046983279
ABSTRACT:
Novel glycopeptide antibiotics of formula (I) can be prepared from the glycopeptide antibiotics vancomycin, A51568A, A51568B, M43A and M43D by reaction with a ketone or aldehyde followed, if appropriate, by reduction. The new glycopeptide derivatives are useful antibacterial agents.
REFERENCES:
patent: 3067099 (1962-12-01), McCormick et al.
patent: 4495179 (1985-01-01), Hoehn et al.
patent: 4547488 (1985-10-01), Merkel
patent: 4548925 (1985-10-01), Higgins, Jr. et al.
patent: 4558008 (1985-12-01), Boeck et al.
Harris et al., "Structure of the Glycopeptide Antibiotic Vancomycin, Evidence for an Asparagine Residue in the Piptide," J. Am. Chem. Soc., 104, 4293-4295 (1982).
Pfeiffer, "Structural Features of Vancomycin," Reviews of Infectious Diseases, vol. 3, Suppl., S205-S209 (Nov.-Dec. 1981).
Nagarajan Ramakrishnan
Schabel Amelia A.
Eli Lilly and Company
Harrison Nancy J.
Phillips Delbert R.
Whitaker Leroy
LandOfFree
Novel glycopeptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel glycopeptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel glycopeptide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2117395